More information: Sudhanshu Shekhar et al, Intranasal immunization with the commensal Streptococcus mitis confers protective immunity against pneumococcal lung infection, Applied and Environmental ...

Vaccinating laboratory mice with Streptococcus mitis bacteria prevents their virulent sibling, Streptococcus pneumoniae from infecting the mice. The research suggests that vaccination of humans ...

Reviewed by Kate Anderton, B.Sc. (Editor) Jan 30 2019 Vaccinating laboratory mice with Streptococcus mitis bacteria prevents their virulent sibling, Streptococcus pneumoniae from infecting the mice.

Vaccinating laboratory mice with Streptococcus mitis bacteria prevents their virulent sibling, Streptococcus pneumoniae from infecting the mice. The research suggests that vaccination of humans ...

Bacteria in the mouth linked to pulmonary fibrosis survival One bacterial species tended to dominate in certain patients with IPF who were not treated with antibiotics Date: February 7, 2024 ...

Group A streptococcus circumvents immune responses through binding to the IgG fragment crystallizable (Fc) region, which prevents opsonization and phagocytosis of bacteria.

Intranasal immunization with the commensal Streptococcus mitis confers protective immunity against pneumococcal lung infection. Applied and Environmental Microbiology, 2019; DOI: 10.1128/AEM.02235-18 ...